Stay updated on DANNOAC-AF: Atrial Fibrillation Clinical Trial
Sign up to get notified when there's something new on the DANNOAC-AF: Atrial Fibrillation Clinical Trial page.

Latest updates to the DANNOAC-AF: Atrial Fibrillation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check63 days agoChange DetectedThe website has updated its contact information for several medical professionals, adding new contacts and removing previous principal investigators, including notable changes in the roles of Thomas Hermann, Louise Schierbeck, and others.SummaryDifference19%
- Check92 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to DANNOAC-AF: Atrial Fibrillation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DANNOAC-AF: Atrial Fibrillation Clinical Trial page.